ArticleAnnals of hematology2026

WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapy.

Hiroyuki Sugiura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.